Position history for JPMORGAN CHASE & CO's holdings in XILIO THERAPEUTICS INC
JPMORGAN CHASE & CO holds 240 shares of XLO (XILIO THERAPEUTICS INC), worth $1,976 as of 2026-Q1. This is a new position.
Current Value
$1,976
Current Shares
240
Total Value Change
+$1,913
Total Shares Change
+174
Other major holders of XLO: RA CAPITAL MANAGEMENT, L.P., NORGES BANK, FIL Ltd
New |
| 240 |
- |
| $1,976 |
| 0.0% |
| $0.53 |
17 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $0.68 | 0 |
| 2025-Q1 | Decreased | 62 | -6.1% | $45 | 0.0% | $0.75 | 0 |
| 2024-Q4 | New | 66 | - | $63 | 0.0% | $0.97 | 17 |